Terug
Dagbereik
€ 18,93
€ 19,91
52-Weeksbereik
€ 1,03
€ 19,91
Volume
2.846.519
50D / 200D Gem.
€ 13,42
/
€ 8,90
Vorige Slotkoers
€ 19,42
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,7 | 0,4 |
| P/B | 6,4 | 2,9 |
| ROE % | -37,2 | 3,7 |
| Net Margin % | -162,9 | 3,8 |
| Rev Growth 5Y % | 13,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue grew 13,92% annually over 5 years — strong growth
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -139,93M
PEG of 0,38 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 34,37%
Capital efficient — spends only 1,68% of revenue on capex
Groei
Revenue Growth (5Y)
13,92%
Revenue (1Y)48,29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-37,23%
ROIC-21,98%
Net Margin-162,85%
Op. Margin-178,39%
Veiligheid
Debt / Equity
0,10
Current Ratio16,32
Interest Coverage0,00
Waardering
P/E Ratio
-21,68
P/B Ratio6,36
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 48,29% | Revenue Growth (3Y) | 30,69% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13,92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 62,38M | Net Income (TTM) | -101,59M |
| ROE | -37,23% | ROA | -25,48% |
| Gross Margin | 96,34% | Operating Margin | -178,39% |
| Net Margin | -162,85% | Free Cash Flow (TTM) | -139,93M |
| ROIC | -21,98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 16,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,68 | P/B Ratio | 6,36 |
| P/S Ratio | 35,31 | PEG Ratio | 0,38 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,20B | Enterprise Value | 2,12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62,38M | 42,07M | 36,53M | 24,86M | 37,04M |
| Net Income | -101,59M | -130,30M | -101,74M | -108,18M | -58,24M |
| EPS (Diluted) | -0,87 | -1,19 | -1,08 | -1,23 | -0,94 |
| Gross Profit | 60,10M | 42,07M | 36,53M | 24,86M | 37,04M |
| Operating Income | -111,29M | -145,60M | -114,17M | -111,07M | -58,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 398,69M | 316,49M | 402,57M | 436,47M | 500,16M |
| Total Liabilities | 52,51M | 116,98M | 149,46M | 186,99M | 155,41M |
| Shareholders' Equity | 346,18M | 199,52M | 253,11M | 249,48M | 344,75M |
| Total Debt | 33,57M | 36,49M | 38,92M | 41,13M | 1,50M |
| Cash & Equivalents | 112,28M | 69,53M | 66,39M | 59,97M | 142,75M |
| Current Assets | 353,76M | 266,34M | 346,54M | 375,27M | 492,34M |
| Current Liabilities | 21,68M | 38,17M | 45,94M | 55,55M | 40,69M |